Tradestie Institutional Equity Comparison Engine

XHE vs XPH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XHE Overall Edge

XHE Captures Institutional Edge (1โ€“1 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SPDR S&P Health Care Equipment ETF (XHE) driven by superior Momentum & Technical while XPH counters with relative strength in Options & Structure. Fundamentally, XHE trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus XPH at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, XHE sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against XPH sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
XHE N/M vs XPH N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner XHE
1Y +13.3% vs +30.6% ยท 52W Pos 72% vs 64%
Options & Structure Winner XPH
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (5th %ile IV)
XHE NYSE Arca
SPDR S&P Health Care Equipment ETF
Institutional Equity
$93.83
-1.1% 1D
Market Cap N/A
1M Return +4.9%
1Y Return +13.27%
Forward P/E N/M
Unified AI Score
46.8 / 100 HOLD
Tech 42.0 Fund 43.0 Flow 50.0 Mom 31.1
XPH NYSE Arca
SPDR S&P Pharmaceuticals ETF
Institutional Equity
$65.58
-1.87% 1D
Market Cap N/A
1M Return +6.05%
1Y Return +30.61%
Forward P/E N/M
Unified AI Score
41.0 / 100 SELL
Tech 37.0 Fund 45.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XHE +13.27% XPH +30.61% Spread: +17.34 pp (XPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
XHE TTM Op. Margin: N/A XPH TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XHE vs XPH. Trailing 12-month operating profitability (XHE N/A vs XPH N/A) and valuation multiples (XHE N/M vs XPH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XHE (2) vs XPH (1)
Institutional Metric XHE XPH Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 72% ($76โ€“$101) 64% ($50โ€“$74) Stronger Trend XHE
Beta / 30D Volatility Risk Regime 0.87ฮฒ ยท 39% Vol 0.87ฮฒ ยท 32% Vol Lower Realized Risk XPH
Unified Institutional Score Composite Signal 46.8 / 100 (HOLD) 41.0 / 100 (SELL) Higher Composite XHE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XHE vs XPH Buy Guide
XHE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live XHE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live XPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XHE nor XPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.